The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PASG

<p>分析师对 Passage Bio (PASG) 的目标价格均值显示该股票有 731% 的上涨空间。尽管这一备受关注的指标并未被证明具有合理的有效性，但分析师在提高盈利预期方面的强烈一致性确实表明该股票有上涨的潜力</p>

华尔街分析师认为 Passage Bio（PASG）可能会有 731% 的涨幅：在下注之前请阅读这篇文章